GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nexalin Technology Inc (NAS:NXL) » Definitions » FCF Yield %

Nexalin Technology (Nexalin Technology) FCF Yield % : -67.95 (As of May. 30, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Nexalin Technology FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Nexalin Technology's Trailing 12-Month Free Cash Flow is $-3.41 Mil, and Market Cap is $5.39 Mil. Therefore, Nexalin Technology's FCF Yield % for today is -67.95%.

The historical rank and industry rank for Nexalin Technology's FCF Yield % or its related term are showing as below:

NXL' s FCF Yield % Range Over the Past 10 Years
Min: -174.99   Med: -57.23   Max: -9.19
Current: -67.95


During the past 4 years, the highest FCF Yield % of Nexalin Technology was -9.19%. The lowest was -174.99%. And the median was -57.23%.

NXL's FCF Yield % is ranked worse than
90.08% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.82 vs NXL: -67.95

Nexalin Technology's FCF Margin % for the quarter that ended in Mar. 2024 was -1,049.37%.


Nexalin Technology FCF Yield % Historical Data

The historical data trend for Nexalin Technology's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nexalin Technology FCF Yield % Chart

Nexalin Technology Annual Data
Trend Dec20 Dec21 Dec22 Dec23
FCF Yield %
- - -40.60 -131.02

Nexalin Technology Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
FCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -93.67 -50.80 -87.30 -138.06 -31.85

Competitive Comparison of Nexalin Technology's FCF Yield %

For the Medical Devices subindustry, Nexalin Technology's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nexalin Technology's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nexalin Technology's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Nexalin Technology's FCF Yield % falls into.



Nexalin Technology FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Nexalin Technology's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %=Free Cash Flow / Market Cap
=-3.944 / 3.010319488
=-131.02%

Nexalin Technology's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %=Free Cash Flow * Annualized Factor / Market Cap
=-0.829 * 4 / 10.411184
=-31.85%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nexalin Technology FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Nexalin Technology FCF Yield % Related Terms

Thank you for viewing the detailed overview of Nexalin Technology's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Nexalin Technology (Nexalin Technology) Business Description

Traded in Other Exchanges
N/A
Address
1776 Yorktown, Suite 550, Houston, TX, USA, 77056
Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.
Executives
Marilyn Elson 10 percent owner, officer: Ms. Elson serves as CFO 32 CAMLET COURT, ROSELAND NJ 07068
Rick Morad director 6331 CHAGRIN RIVER ROAD, BENTLEYVILLE OH 44022
Mark White director, officer: President/CEO 1776 YORKTOWN STREET, SUITE 550, HOUSTON TX 77056
David Owens director, officer: Chief Medical Officer 4545 HARRIS TRAIL NW, ATLANTA GA 30327
Alan Kazden director 3435 CONSUELO DRIVE, CALABASAS CA 91302
Leonard Osser other: Spouse
Ben Hu director 7021 EDGERTON ROAD, NORTH ROYALTON OH 44133

Nexalin Technology (Nexalin Technology) Headlines

From GuruFocus

Nexalin Technology CEO Provides Letter to Shareholders

By Stock market mentor Stock market mentor 01-05-2023

Nexalin Technology Provides 2022 Year-End Business Update

By sperokesalga sperokesalga 03-27-2023